An appeal and an international case review address different questions.

An insurance appeal asks whether coverage for the requested treatment can be reconsidered. The outcome depends on the insurer’s criteria, process, and timeline.

An international case review asks whether another clinically appropriate and feasible treatment pathway exists.

This distinction matters not only when treatment is denied, but also when care is delayed, unavailable locally, or financially out of reach.

In some situations, an appeal and an international review can proceed in parallel. This allows patients to challenge the coverage decision while also assessing whether international treatment is feasible within the available timeframe and budget.

Whether treatment abroad is realistic depends on the patient’s condition, ability to travel, timing, cost, and the receiving hospital’s review.

APIS coordinates communication with Korean hospitals for international case reviews.